Vitrolife AB
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 3.6B 3.5B 3.2B 1.7B
Cost of revenue 1.5B 1.5B 1.5B 635M
Gross profit 2.1B 2.0B 1.8B 1.0B
Operating expense
Research & development 117M 127M 143M 114M
Selling general and admin 1.2B 1.1B 1.0B 503M
Other operating expenses 9M -11M 2M
Operating income 791M 738M 647M 428M
Non operating interest income
Income 24M 16M 2M 1M
Expense 98M 94M 44M 10M
Other income expense
Pretax income 674M -3.7B 537M 460M
Tax provision 160M 139M 143M 116M
Net income 513M -3.9B 394M 344M
Basic EPS 3.8 -28.4 2.9 3.0
Diluted EPS 3.8 -28.4 2.9 3.0
Basic average shares 135.4M 135.4M 135.4M 114.6M
Diluted average shares 135.4M 135.4M 135.4M 114.6M
EBITDA 1.2B -3.1B 995M 577M
Net income from continuing op. 674M -3.7B 537M 460M
Minority interests -1M 0 0 -3M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 9 hours 37 minutes

23:22
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).